{"id":"W4280594357","doi":"10.1016/s2352-3026(22)00102-8","title":"Ruxolitinib versus best available therapy in inadequately controlled polycythaemia vera without splenomegaly (RESPONSE-2): 5-year follow up of a randomised, phase 3b study","year":2022,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Novartis Pharmaceuticals Corporation; Novartis","keywords":"Ruxolitinib; Medicine; Polycythaemia; Clinical endpoint; Internal medicine; Phlebotomy; Myelofibrosis; Polycythemia vera; Clinical trial; Randomized controlled trial; Pediatrics; Surgery; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003764342,0.002208806,0.004748315,0.0004951342,0.0005323117,0.002144322,0.001275099,0.002730334,0.005078533],"category_scores_gemma":[0.002625786,0.000819802,0.004207827,0.0005242404,0.001502845,0.002087883,0.0005634366,0.004731173,0.001377318],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001126749,"about_ca_system_score_gemma":0.0007708083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001433605,"about_ca_topic_score_gemma":0.002411742,"domain_scores_codex":[0.9985206,0.0008267212,0.00006248998,0.0002001118,0.00008733886,0.0003027808],"domain_scores_gemma":[0.9977877,0.0007303657,0.0005101901,0.0002513948,0.0001079531,0.0006123065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9753425,0.004049369,0.0009061025,0.0004165779,0.001437541,0.00007228248,0.00007199903,0.0005068989,0.001933128,0.0000758837,0.0008571356,0.01433055],"study_design_scores_gemma":[0.9187267,0.07285008,0.005778559,0.00005460557,0.0009084132,0.00009000061,0.00005224392,0.0004257834,0.0002997152,0.0001907913,0.0005920504,0.000031075],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874692,0.00695086,0.0004677938,0.0009032423,0.0004436364,0.000767282,0.00138649,0.0001120263,0.001499489],"genre_scores_gemma":[0.9893956,0.002751364,0.000739941,0.001200696,0.0005063787,0.0009443114,0.001628911,0.00004411909,0.002788772],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005078533,"threshold_uncertainty_score":0.01990801,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08405562557028219,"score_gpt":0.35526130428884,"score_spread":0.2712056787185578,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}